Role of dual PI3/Akt and mTOR inhibition in Waldenstrom's Macroglobulinemia.

Oncotarget

Volumn 1, Issue 7, 2010, Pages 578-582

  Sacco, Antonio ^a   Roccaro, Aldo ^b   Ghobrial, Irene M ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; MTOR PROTEIN, HUMAN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE INHIBITOR; TARGET OF RAPAMYCIN KINASE;

DRUG ANTAGONISM; DRUG EFFECT; EVALUATION; HUMAN; METHODOLOGY; MOLECULARLY TARGETED THERAPY; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; TREATMENT OUTCOME; WALDENSTROEM MACROGLOBULINEMIA;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; HUMANS; MOLECULAR TARGETED THERAPY; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; TREATMENT OUTCOME; WALDENSTROM MACROGLOBULINEMIA;

EID: 79958011128     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.192     Document Type: Review

References (0)